BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1346 related articles for article (PubMed ID: 26687641)

  • 1. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia].
    Gamba C; Schroeder J; Citterio A; Cazzaniga S; Rivolta AL; Vighi G;
    Recenti Prog Med; 2014 Oct; 105(10):379-84. PubMed ID: 25282350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study.
    Rodríguez-Martín S; Martín-Merino E; Lerma V; Rodríguez-Miguel A; González O; González-Herrada C; Ramírez E; Bellón T; de Abajo FJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):237-246. PubMed ID: 30298362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Devarbhavi H; Raj S; Aradya VH; Rangegowda VT; Veeranna GP; Singh R; Reddy V; Patil M
    Hepatology; 2016 Mar; 63(3):993-9. PubMed ID: 26439084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lipowicz S; Sekula P; Ingen-Housz-Oro S; Liss Y; Sassolas B; Dunant A; Roujeau JC; Mockenhaupt M
    Br J Dermatol; 2013 Apr; 168(4):726-32. PubMed ID: 23413807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
    Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
    Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
    Yamane Y; Aihara M; Ikezawa Z
    Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
    Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
    Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.
    Park HJ; Kim SR; Leem DW; Moon IJ; Koh BS; Park KH; Park JW; Lee JH
    Eur J Clin Pharmacol; 2015 Jan; 71(1):35-41. PubMed ID: 25327504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.